Subsequent in vitro and in vivo studies characterized the biological consequences of this molecular abnormality, demonstrating that HER2 is a potent oncogene that promotes tumor growth, angiogenesis and metastasis [3]–[5]. The gene discussed is ERBB2; the disease is neoplasm.